Fruit fly gene study could yield new flu treatments

As they design new drugs to fight off influenza, scientists may not need to attack the virus directly. Instead, they may be able to stave off infection by targeting one of more than 100 proteins inside host cells on which the virus depends.

These potential drug targets are the result of a study in which scientists, led by Howard Hughes Medical Institute investigator Paul Ahlquist and colleague Yoshihiro Kawaoka at the University of Wisconsin-Madison, tested the ability of a modified influenza virus to infect fruit fly cells. "Our findings give us considerable hope that—with a large number of host targets to choose from—we could develop drugs to more stably suppress the virus and not allow the virus to evolve nearly as quickly to generate resistance," Ahlquist said. The team described their findings in a July 9, 2008, advance online publication of the journal Nature.

Viruses possess only a limited number of genes, so they must hijack a host cell's own protein machinery to enter the cell and replicate their genes. Relatively few of influenza's interactions with host proteins are understood, according to Ahlquist, and this has limited drug development.

"So far, antiviral treatments against influenza have targeted specific viral enzymes or functions," he said. "The problem has been that the virus can mutate itself to develop resistance to these drugs. Our hope is that by identifying host functions on which the influenza virus depends, we can develop drugs that target these functions. And since those functions are encoded by the host, the virus cannot use simple mutations to develop resistance to such drugs."

Although fruit flies are not naturally infected by the influenza virus, Ahlquist and his colleagues knew the fly would be a powerful tool in identifying the genes and proteins that facilitate infection. A great many fly genes have counterparts in humans, and the researchers could analyze the function of individual fly genes using a technique known as RNA interference. So the researchers genetically altered influenza virus so that it could infect cultured fruit fly cells grown in the laboratory. They also added a gene that would produce a telltale fluorescence when the virus successfully replicated in fly cells.

They next used RNA interference -- treating fly cells with small snippets of RNA -- to individually suppress the function of each of 13,071 genes, representing 90 percent of all fly genes. If a gene is important for allowing the virus to replicate, fly cells in which that gene had been shut off would not emit the fluorescent signal signifying infection. Using this screen, the researchers identified more than 100 host cell genes that the virus depended on for infection.

"We found that the virus depends on the function of fly genes in a wide range of cellular processes," said Ahlquist. "This tells us that quite a variety of host functions are important to the virus and that there could be a broad range of options for antiviral drugs."

The researchers wanted to be sure that their findings were relevant for influenza infections that occur outside of the laboratory. So, as an initial check, they tested the ability of natural strains of the virus to infect mammalian cells lacking three of the genes they had identified in the fruit fly cells. The genes they chose participate in three different cellular processes known to be involved in the life cycle of the virus. They found that suppressing the function of any of the three diverse genes—called ATP6V0D1, COX6A1 and NXF1—thwarted viral replication.

The researchers also tested how blocking these genes might affect infection with other viruses, and found that all three genes were influenza-specific. Suppressing them did not affect replication of two other viruses they tested. Thus, said Ahlquist, the influenza virus functions in a way that is distinct from the other viruses and that may offer a prime target for influenza-specific antiviral drugs.

Source: Howard Hughes Medical Institute

Scientists identify key roadblock to gene expression
A team of scientists has provided, for the first time, a detailed map of how the building blocks of chromosomes, the cellular structures that contain genes, are organized in the fruit fly Drosophila melanogaster. The work identifies a critical stop sign for transcription, the first step in gene expression, and has implications for understanding how the AIDS virus regulates its genes. The findings will be published in the 15 May 2008 issue of the journal Nature.
Pathway found that lets mosquitoes fatten up, slow down for winter
Two genes that help insulin regulate mosquitoes’ growth have been identified as key contributors to how the insects enter a dormant state to survive winter’s cold. The research finding broadens the understanding of the mosquito life cycle and appears to shed some light on how other insects and invertebrate species weather the winter months.
Flying off course: Why migratory birds from Asia land in Europe
Migratory birds make mistakes in terms of direction, but not distance. These are the findings of a team of ornithologists and ecologists from the University of Marburg, the Ornithological Society in Bavaria and the Helmholtz Centre for Environmental Research (UFZ), writing in the Journal of Ornithology.
Fruit fly gene from 'out of nowhere' is discovered
Scientists thought that most new genes were formed from existing genes, but Cornell researchers have discovered a gene in some fruit flies that appears to be unrelated to other genes in any known genome.
First all-African produced genetically engineered maize is resistant to maize streak virus
Maize streak viruses (MSV), geminiviruses that can destroy most of a maize crop, are endemic to sub-Saharan Africa and adjacent Indian Ocean islands where they are transmitted by leafhoppers in the genus Cicadulina. Maize can supply 50% of the caloric intake in sub-Saharan Africa but, in certain years, a farmer’s entire crop can be wiped out. Now, scientists at the University of Cape Town, South Africa, along with colleagues at the South African seed company, PANNAR Pty Ltd, have developed a resistant variety of maize that they hope will help alleviate food shortages as well as promote the reputation of genetically engineered (GE) foods in Africa.
K-State biologist hopes mosquito can break viral chain
Most people do their best to avoid mosquitoes. But this summer Rollie Clem will play the wary host to his own homegrown swarm of Aedes aegypti, the yellow fever mosquito. He's made a room ready for them, and even a menu.
'Insulator' helps silence genes in dormant herpes virus
By adulthood, most people have suffered at least one bout of painful cold sores brought on by the Herpes simplex virus 1, also known as HSV-1. After the initial infection, the virus usually remains in the body, hiding out in nearby nerve cells where the victim's immune defenses cannot reach it, causing no symptoms at all.
Researchers developing better wheat
Eighteen universities across the United States are combining desirable genes from different varieties of wheat to make better and more competitive varieties.

Fruit fly gene study could yield new flu treatments

Related stories:

News discussion: